Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ATP128 |
Trade Name | |
Synonyms | ATP 128|ATP-128 |
Drug Descriptions |
ATP128 is a chimeric protein vaccine that potentially modify antigen presentation of dendritic cells, leading to activation of immune response against tumor cells (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C165621 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ATP128 | ATP128 | 0 | 1 |
ATP128 + Ezabenlimab | ATP128 Ezabenlimab | 0 | 1 |
ATP128 + Ezabenlimab + VSV-GP128 | ATP128 Ezabenlimab VSV-GP128 | 0 | 1 |